← FDA Drug Approvals (Drugs@FDA)
SUTAB
NDA · New Drug Application · Sponsor: AZURITY · Approved 2020-11-10
Drug application
- FDA Application #
NDA213135- Application type
- New Drug Application
- Brand name
- SUTAB
- Generic name
- SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE
- Active ingredients
- MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AZURITY
- Manufacturer
- Azurity Pharmaceuticals, Inc.
- First approval
- 2020-11-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown